ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety and Efficacy Study of Adjunctive Rosiglitazone in the Treatment of Uncomplicated Falciparum Malaria

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00149383
Recruitment Status : Completed
First Posted : September 8, 2005
Last Update Posted : April 13, 2015
Sponsor:
Collaborator:
McLaughlin-Rotman Center for Global Health, University of Toronto
Information provided by (Responsible Party):
Mahidol University

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : November 2005
  Actual Study Completion Date : January 2006
Publications:

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):